The Indianapolis-based drugmaker earned $1.06 billion, or 97 cents a share, compared with $508.7 million, or 47 cents per share, in the year-earlier period.
NEW YORK (Reuters) - Eli Lilly and Co <LLY.N> said on Monday its first-quarter earnings rose on higher sales of its treatments for diabetes, cancer and depression.
The Indianapolis-based drugmaker earned $1.06 billion, or 97 cents a share, compared with $508.7 million, or 47 cents per share, in the year-earlier period.
(Reporting by Euan Rocha and Ransdell Pierson; Editing by Derek Caney)
